GSK supports recovery efforts to help those affected by the Japan earthquake
- Details
- Category: GlaxoSmithKline
In response to events in Japan as a result of the Tohoku Kanto Earthquake and tsunami that devastated Japan's north east coastline region, GlaxoSmithKline (GSK) is supporting the ongoing relief efforts by working with the Japanese authorities,
Novartis committed to provide equivalent of more than USD 3 million in relief aid to Japan earthquake victims
- Details
- Category: Novartis
Novartis has committed to providing the equivalent of over USD 3 million in immediate relief aid to the victims of the recent earthquake in Japan.
MorphoSys Signs Manufacturing Agreement with Boehringer Ingelheim
- Details
- Category: Boehringer Ingelheim
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and Boehringer Ingelheim announced the signing of a biopharmaceutical manufacturing agreement for therapeutic antibodies.
NAFE Names Lilly to Top 50 Companies for Executive Women
- Details
- Category: Eli Lilly and Company
Eli Lilly and Company (NYSE: LLY) has been named to the 2011 NAFE Top 50 Companies for Executive Women by the National Association for Female Executives (NAFE).
GSK announces positive topline results of Phase lll study of IPX066 in advanced Parkinson's disease
- Details
- Category: GlaxoSmithKline
GlaxoSmithKline (GSK) announced positive, top-line results of the ADVANCE-Parkinson's Disease (PD) Phase III clinical study, conducted by Impax Pharmaceuticals, of IPX066 versus immediate-release (IR) carbidopa-levodopa (CD-LD) in advanced PD patients experiencing motor fluctuations.
Amgen Donates $1 Million to Help Japanese Disaster Victims
- Details
- Category: Amgen
Amgen (Nasdaq: AMGN) announced that the company will donate $1 million to Japanese disaster relief efforts. Amgen and the Amgen Foundation will distribute the funds to both Direct Relief International and International Medical Corps to bring basic needs and vital health services to those affected in Japan.
Abbott Supports Relief Efforts in Japan
- Details
- Category: Abbott
Abbott (NYSE: ABT), through its philanthropic foundation the Abbott Fund, is providing $3 million (245 million yen) to support immediate relief efforts in response to the devastating earthquake and tsunami in Japan.
More Pharma News ...
- OncoTrack: A new International consortium launches project in the area of genomic cancer diagnostics
- GlaxoSmithKline and Human Genome Sciences announce FDA approval of Benlysta® (belimumab)
- FDA accepts new drug application for investigational compound Dapagliflozin
- Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares
- Pfizer Announces Primary Endpoints Met in Second Phase 3 Clinical Trial of Tofacitinib
- Bayer extends support to fight Chagas disease
- Breakaway From Cancer(R) Launches Newly-Enhanced Website